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Understanding the interaction between social and economic circumstances and health
over the life course is important to develop policies not only to improve peoples
health but also their social and economic capacities. While much research has been
produced across different disciplines to examine these issues, they are often limited by
their disciplinary base: social science research often treats health as a unitary concept,
while biomedical studies generally control for a single measure of socioeconomic
status (Herd et al, 2007). However, what is needed are studies that bring together the
richness of social science and health data, analysed by researchers with expertise
across biomedical and social disciplines, to understand the complex social and
biological processes that link different aspects of peoples lives and health at different
life stages. Including biomarkers in established high quality social science longitudinal
surveys is one way to do this. Biomarkers are biological or physiological measures that
indicate the presence of a disease or the propensity to develop a disease. They can be
used to identify risk factors over the lifecourse and as objective measures of health
that avoid contamination by reporting bias (see, e.g., Adda and Cornaglia, 2006; Banks
et al., 2006). Such evidence will help to inform policies about how and when to
intervene to improve population health and reduce health inequalities.
Longitudinal research shows the importance of biological and psychological
development (which can be measured by biomarkers) at each stage of life, beginning
in utero, for health well-being, behaviours, social and economic status at later ages.
Research has attempted to address a wide range of questions; for example, are life
course processes a matter of the accumulation of risk factors or do factors at each
2stage matter independently or interact in different ways? Or are there critical periods
during which certain types of development must take place if they are ever to happen?
Do experiences at some points in the life course influence the response to adversities
that may happen later? How do early life and socioeconomic circumstances combine
to influence adult outcomes? These questions are complex given that societal
institutions such as the family, the education system, the structures and conditions of
employment, fiscal and welfare policies may produce a variety of life courses
regardless of individual biological or psychological differences. These institutions,
which have long served to define important life transitions, are in constant change
themselves.
Few studies have sufficient environmental, institutional, fiscal, psychological and
biological data to attempt to address these questions, one that has developed such a
resource is Understanding Society: the UK Household Longitudinal Study(UKHLS)
Understanding Society: the UK Household Longitudinal Survey (UKHLS)
UKHLS is one of the largest household panel studies in the world. It is funded by the
Economic and Social Research Council with co-funding from a number of Government
Departments, and led by the Institute of Social and Economic Research at the
University of Essex. Begun in 2009, it has four samples: two of which have received a
nurse interview, which collected biomarker data: the general population sample (GPS);
and households from the British Household Panel Survey (BHPS), which has been
running since 1991.
UKHLS, and BHPS before it, conducts annual interviews covering all members of the
household, although in UKHLS fieldwork for each wave takes two calendar years.
Information on children under 10 is gathered from the primary carer (generally
mothers), those aged 10-15 are given a self-complete questionnaire, while those aged
16 and over complete a face-to-face interview. The questionnaire covers a wide range
of questions about peoples families, employment and education, housing and
neighbourhoods, consumer durables, savings, wealth and income, health, health
behaviours and wellbeing, cognition and personality, social support and engagement,
health, transport, leisure, environmental and political behaviours. UKHLS also provides
researchers with the ability to link to a wide variety of different geographies so that
they can add different contextual material, as well as asking consent to link to
government administrative records.
All people aged 16+ years who took part in the relevant main wave(wave 2 for GPS
and wave 3 for BHPS) were selected for follow up, provide they had conducted their
main interview in English and lived in Great Britain. In the second year of wave 2, in
order to accommodate the BHPS sample interviews, a sampling fraction of 0.81 was
applied to the GPS participants. In total therefore, across the two samples 35,563
respondents were eligible for the nurse interview, and 20,644 (58%) took part. Of
these, approximately 67% have consent to give blood and provide DNA, and samples
3were successfully taken on 13,571. Longitudinal weights have been produced to
ensure the main nurse measures, and blood related data are representative of the
general population. As a result, comprehensive longitudinal socioeconomic data have
been linked to biomarkers that include physical measurements and blood analytes
(Benzeval et al., 2014).
The interviews, which lasted an hour, took place in respondents homes approximately
5 months after the main survey. A range of physical measures were taken: including
blood pressure, lung function, waist circumference, height, weight and body fat and
grip strength. Blood samples were taken and have subsequently been analysed by
Newcastle NHS Trust to produce 20 analytes, which capture key chronic diseases, and
processes relating to stress and ageing. They include coronary heart disease (blood
pressure, body fat, cholesterol and triglycerides); diabetes (HbA1c); liver disease
(LFTs); kidney function (creatinine, urea); anaemia and poor nutrition (Hb, ferritin);
inflammatory markers (CRP, fibrinogen, CMV); and hormones (testosterone, IGF-1,
DHEAs). DNA was extracted and genotyping performed by the Sanger Institute using
the Illumina HumancoreExome chip for approximately 10,500 respondents of white
European descent. These measured markers have been employed with the UK10k
reference dataset to impute more than 10million common sequence variants. Genetics
data alone is available at the EGA and combined with survey data at
https://www.understandingsociety.ac.uk/about/health/data.
Research potential of biomarker and longitudinal social data
The availability of objectively measured biomarker data has two key advantages over
self-report data. First, they provide measures of health that are free of reporting bias;
given the intense debate around the extent of socioeconomic-related reporting bias
(e.g., Bago dUva et al., 2008) this is a significant advantage in research on
socioeconomic inequalities in health. For example, biomarker data have been used to
analyse the effect of socioeconomic position on the conditional mean of biomarker
scores (Banks et al., 2006; Juerges et al., 2013; Muennig et al., 2007; Ploubidis et al.,
2014; Dowd and Goldman, 2006). Secondly, biomarkers allow researchers to
investigate biological factors that contribute to and interact with health, education,
and social conditions. When combined with the longitudinal data, biomarkers can shed
light on the complex interplay between biology, behaviour, and environment over the
life course for both health and other outcomes.
Data suggest two pressing issues: the ageing population, with its attendant increase in
disability and disease, and an increase in psychological distress in recent generations.
Indeed depression is currently rated as the second most common cause of disability by
WHO. There is a near ubiquitous finding of differences in health and functioning by
social position. However, the reasons for these differences are still unclear. The
shadow of adversity in childhood and its impact on mental health in later life is well
established. However, the specific causal chains and life-course trajectories remain to
be elucidated and biological pathways that may mediate these relationships are less
4well established. A number of pathways have been implicated, these include the
immune system, endocrine function, which is specifically related to gender differences
in mental health, and cardiovascular risk, which is implicated in older age depression.
Methodological challenges and opportunities
The appropriate treatment of biomarker and genetic data in statistical analyses plays a
vital role in the production of high-quality scientific findings. The biostatistical
literature on using such data is more developed than that in social statistics and
econometrics, but the basic techniques are very similar at heart, albeit divided by
differences in emphasis and terminology. In health economics there is a wide literature
on approaches to modelling patient-level cost data and their relative performance (for
example Jones et al., 2015a). Much research to date has focused on the prediction of
average costs for different types of patient. This can potentially miss important
features such as the likelihood of extreme values. For example, Jones et al. (2015b)
compare methods for fitting the distribution of healthcare costs that go beyond the
mean. The distributions of biomarkers share many of the features of health care costs
and these methods may be applied to find the model that best fits each outcome. For
example, Carrieri & Jones (2016) we have explored the impact of income across the full
distribution of the biomarkers measured in the Health Survey for England.
Causality is difficult to ascertain using conventional observational methodologies,
given well-known problems of confounding and reverse causality. While longitudinal
studies provide a partial solution, but are often limited by poor temporal resolution,
unmeasured confounding and limited statistical power. One potential solution to these
difficulties lies in the application of the principle of Mendelian randomisation (MR). MR
involves the use of specific genetic variants that have been shown to be robustly
associated with a specific exposure (e.g., diabetes); these are then used as proxies for
the exposure. The principle of MR relies on the basic (but approximate) laws of
Mendelian genetics (segregation and independent assortment). If these two laws hold
then, at a population level, genetic variants will not be associated with the
confounding factors that generally distort conventional observational studies. Whilst it
is not possible to fully prove this priniciple, it has been demonstrated that associations
of genetic variants with measured confounders occur at rates consistent with chance,
but measured exposures associate with confounding factors much more frequently. In
addition, the genes that individuals are born with should not be altered by
environmental factors, which removes the issue of reverse causality. Often there are a
large number of genetic loci relevant to a particular condition (such as obesity,
metabolic markers and diabetes). Research is therefore beginning to employ multi-SNP
genetic instrument to increase both the power of the genetic instrument and its
specificity. Given the relatively small effects that individual genetic variants exert on
exposures, MR analyses generally require large sample sizes, which can only be
achieved through collaborative consortia.
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Research that combines longitudinal socioeconomic data with biomarkers and genetic
markers, using appropriate methodologies, has the potential to add to our
understanding of how social and economic circumstances interact with health over the
life course, and some of the biological pathways that underpin this. These new data in
UKHLS enable researchers to do this, and we are developing both our own research
activities as well as capacity building events to support and develop such new research
agendas. Such research by us and more broadly will shed light on the complexities of
associations between the social and biological for example when inequalities in
different dimensions of health emerge and what some of the underlying pathways may
be. This will help identify interventions and mechanisms that may help to promote
population health and reduce inequalities in health.
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